<p>Vecuronium bromide is a non-depolarising neuromuscular blocking agent. It blocks the transmission process between the motor nerve-ending and striated muscle by binding competitively with acetylcholine to the nicotinic receptors located in the motor end-plate region of striated muscle.<br />
<br />
Unlike depolarising neuromuscular blocking agents, such as suxamethonium, Vecuronium bromide does not cause muscle fasciculations.<br />
<br />
Within the clinical dosage range, Vecuronium bromide exerts neither vagolytic nor ganglion blocking activity.</p>